loading...| Preferred Name |
sodium selenite |
|
| Synonyms |
|
|
| Definitions |
An inorganic form of the trace element selenium with potential antineoplastic activity. Selenium, administered in the form of sodium selenite, is reduced to hydrogen selenide (H2Se) in the presence of glutathione (GSH) and subsequently generates superoxide radicals upon reaction with oxygen. This may inhibit the expression and activity of the transcription factor Sp1; in turn Sp1 down-regulates androgen receptor (AR) expression and blocks AR signaling. Eventually, selenium may induce apoptosis in prostate cancer cells and inhibit tumor cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C87346" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C87346" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000681583 |
|
| cui |
C0142923 |
|
| DATE FIRST PUBLISHED |
2010-07-08 |
|
| Date last modified |
2010-12-28 |
|
| definition |
An inorganic form of the trace element selenium with potential antineoplastic activity. Selenium, administered in the form of sodium selenite, is reduced to hydrogen selenide (H2Se) in the presence of glutathione (GSH) and subsequently generates superoxide radicals upon reaction with oxygen. This may inhibit the expression and activity of the transcription factor Sp1; in turn Sp1 down-regulates androgen receptor (AR) expression and blocks AR signaling. Eventually, selenium may induce apoptosis in prostate cancer cells and inhibit tumor cell proliferation. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C87346" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C87346" NCI Thesaurus) |
|
| NCI ID |
C87346 |
|
| notation |
CDR0000681583 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
sodium selenite |
|
| tui |
T197 T121 |